Abstract
The identification of protein-coding genes is currently based on the merging of evidence and predictions from a variety of databases that may themselves contain inaccurate and partial information. We have developed a method for mapping accurate interpretations of protein MS-MS data to the genome. This approach enables verification of genes, exons, transcripts and variant transcripts as well as the de novo discovery of novel protein-coding genes. Here we describe improvements in spectral interpretation algorithms, multiple separation techniques, sub-cellular fractionation and novel bioinformatics approaches to characterise more than 14,000 naturally occurring human genes.
Keywords: proteomics, genome, human, genes, protein isoforms, bioinformatics
Current Proteomics
Title: Annotation of the Human Genome by High-Throughput Sequence Analysis of Naturally Occurring Proteins
Volume: 1 Issue: 1
Author(s): Simon J. McGowan, Jonathan Terrett, Clive G. Brown, Paul J. Adam, Louise Aldridge, Jason C. Allen, Bob Amess, Kristian A. Andrews, Martin Barnes and David E. Barnwell
Affiliation:
Keywords: proteomics, genome, human, genes, protein isoforms, bioinformatics
Abstract: The identification of protein-coding genes is currently based on the merging of evidence and predictions from a variety of databases that may themselves contain inaccurate and partial information. We have developed a method for mapping accurate interpretations of protein MS-MS data to the genome. This approach enables verification of genes, exons, transcripts and variant transcripts as well as the de novo discovery of novel protein-coding genes. Here we describe improvements in spectral interpretation algorithms, multiple separation techniques, sub-cellular fractionation and novel bioinformatics approaches to characterise more than 14,000 naturally occurring human genes.
Export Options
About this article
Cite this article as:
McGowan J. Simon, Terrett Jonathan, Brown G. Clive, Adam J. Paul, Aldridge Louise, Allen C. Jason, Amess Bob, Andrews A. Kristian, Barnes Martin and Barnwell E. David, Annotation of the Human Genome by High-Throughput Sequence Analysis of Naturally Occurring Proteins, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488298
DOI https://dx.doi.org/10.2174/1570164043488298 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner
Current Cancer Therapy Reviews Anti-inflammatory, Antioxidant, Lung and Liver Protective Activity of <i>Galaxaura oblongata</i> as Antagonistic Efficacy against LPS using Hematological Parameters and Immunohistochemistry as Biomarkers
Cardiovascular & Hematological Agents in Medicinal Chemistry Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design In vitro Measurement and In vivo Prediction of Time-Dependent Inhibitory Effects of Three Tyrosine Kinase Inhibitors on CYP3A Activity
Current Drug Metabolism Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Evaluation of Polygonum bistorta for Anticancer Potential Using Selected Cancer Cell Lines
Medicinal Chemistry Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
Current Drug Targets From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Current Neuropharmacology Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In vitro
Current Drug Delivery Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application
Mini-Reviews in Medicinal Chemistry Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Current Medicinal Chemistry Insertional Mutagenesis by Retroviral Vectors: Current Concepts and Methods of Analysis
Current Gene Therapy Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family
Current Drug Therapy The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells
Current Drug Delivery Rho-Signaling Pathways in Chronic Myelogenous Leukemia
Cardiovascular & Hematological Disorders-Drug Targets New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension
Current Medicinal Chemistry